Cardiovascular Systems - CSII Stock Forecast, Price & News

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cardiovascular Systems in the last year. There are currently 1 sell rating, 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Cardiovascular Systems stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CSII, but not buy additional shares or sell existing shares.
View analyst ratings for Cardiovascular Systems or view top-rated stocks.

5 Wall Street research analysts have issued 1 year price objectives for Cardiovascular Systems' stock. Their CSII stock forecasts range from $20.00 to $49.00. On average, they expect Cardiovascular Systems' share price to reach $36.33 in the next twelve months. This suggests a possible upside of 119.5% from the stock's current price.
View analysts' price targets for Cardiovascular Systems or view top-rated stocks among Wall Street analysts.

Cardiovascular Systems' stock was trading at $18.78 at the beginning of 2022. Since then, CSII shares have decreased by 11.9% and is now trading at $16.55.
View the best growth stocks for 2022 here.

Cardiovascular Systems is scheduled to release its next quarterly earnings announcement on Tuesday, November 8th 2022.
View our earnings forecast for Cardiovascular Systems.

Cardiovascular Systems, Inc. (NASDAQ:CSII) announced its earnings results on Monday, November, 8th. The medical device company reported ($0.22) EPS for the quarter, missing the consensus estimate of ($0.10) by $0.12. The medical device company earned $58.40 million during the quarter, compared to analysts' expectations of $63.72 million. Cardiovascular Systems had a negative net margin of 15.64% and a negative trailing twelve-month return on equity of 14.40%. The company's revenue was down 3.5% compared to the same quarter last year. During the same period in the previous year, the company posted ($0.05) earnings per share.

Cardiovascular Systems updated its FY 2023 earnings guidance on Wednesday, August, 3rd. The company provided EPS guidance of for the period. The company issued revenue guidance of $255.00 million-$265.00 million, compared to the consensus revenue estimate of $236.73 million.

12 employees have rated Cardiovascular Systems CEO Scott Ward on Glassdoor.com. Scott Ward has an approval rating of 81% among Cardiovascular Systems' employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Cardiovascular Systems investors own include Gilead Sciences (GILD), AbbVie (ABBV), Advanced Micro Devices (AMD), Medtronic (MDT), Pfizer (PFE), Xcel Energy (XEL), ACADIA Pharmaceuticals (ACAD), Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK) and Procter & Gamble (PG).

Cardiovascular Systems trades on the NASDAQ under the ticker symbol "CSII."

Cardiovascular Systems' stock is owned by a variety of institutional and retail investors. Top institutional investors include Assenagon Asset Management S.A. (2.11%), Allspring Global Investments Holdings LLC (0.19%), SG Americas Securities LLC (0.13%), Russell Investments Group Ltd. (0.12%), M&T Bank Corp (0.10%) and Envestnet Asset Management Inc. (0.10%). Company insiders that own Cardiovascular Systems stock include Alexander Rosenstein, Erik Paulsen, Jeffrey S Points, Martha Goldberg Aronson, Rhonda J Robb, Sandra Sedo and Scott R Ward.
View institutional ownership trends for Cardiovascular Systems.

Shares of CSII stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CSII stock can currently be purchased for approximately $16.55.

Cardiovascular Systems (NASDAQ:CSII) has a market capitalization of $674.91 million and generates $236.22 million in revenue each year. The medical device company earns $-13,420,000.00 in net income (profit) each year or ($0.95) on an earnings per share basis.

Cardiovascular Systems employs 780 workers across the globe.

Cardiovascular Systems was founded in 1989.

Cardiovascular Systems' mailing address is 1225 OLD HWY 8 NW, ST. PAUL MN, 55112. The official website for Cardiovascular Systems is www.csi360.com. The medical device company can be reached via phone at (651) 259-1600, via email at j.nielsen@csi360.com, or via fax at 612-677-3355.